Home · Stock · SDGR

SDGR Schrodinger Inc

Which ETFs hold SDGR? Schrodinger Inc is held by 1 fund tracked by ETFpeek.

Held by 1 fund todayData as of 30 Oct 2026
HealthcareHealth Information Services
$27.14
+29.0% 1y
$10.9552-week range$33.78
Market cap
$2.0B
3-month
+79.3%
CEO
Dr. Ramy Farid Ph.D.
Revenue · last 4 qtrs (+7.5% YoY)

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Provider

Currently Held By

ARK
ARKG
ARK Genomic Revolution ETF
Weight in fund2.94%
Shares held2,356,399
Market value$70.7M
View fund →
Not held by the selected provider.
last 90 days
No insider activity recorded in the last 90 days.
4 trades
DateFundDirectionShares Changed% Δ ETF i% Δ Position i
14 Aug 2026ARKGBUYAdded+28,178+0.03%1.32%
12 Aug 2026ARKGBUYAdded+16,060-0.01%0.77%
10 Aug 2026ARKGBUYAdded+29,975-0.06%1.46%
7 Aug 2026ARKGBUYAdded+48,584+0.27%2.33%
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

More stocks in these funds